Zim Laboratories Ltd Financials
Company Logo

Zim Laboratories Ltd Financial Statement

Zim Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue82.98
Operating Expense74.13
Net Profit0.76
Net Profit Margin0.92
Earning Per Share0.16
EBIDTA8.75
Effective Tax Rate2.37

Zim Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual365.47
Operating Expenses Annual325.37
Operating Profit Annual44.79
Interest Annual6.92
Depreciation13.08
Net Profit Annual16.76
Tax Annual6.28

Zim Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning1.11
Cash Flow from Operations11.47
Cash Flow from Investing-71.94
Cash Flow from Financing59.53
Cash Flow at the End0.17

Zim Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)12.26
PBIT Margin (%)8.20
PBT Margin (%)7.02
Net PROFIT Margin (%)4.59
Return On Networth / Equity (%)7.87
Return On Networth /Employed (%)9.99
Return On Assets (%)5.59
Total Debt / Equity (X)0.41
Asset Turnover Ratio (%)1.22

Zim Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual177.22
Total Current Assets Annual217.71
Non Current Assets Annual224.79
Total Shareholders Funds Annual231.95
Total Assets Annual442.50

Zim Laboratories Ltd Earning Calls

EPS (INR)

Expected

0.18

Reported

0.18

Surprise

0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Sep 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 5, 2024, Zim Laboratories Ltd has a market capitalization of 465.33 Cr. Value Research classifies it as a Small-Cap company.
Yes, Zim Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.47.
In FY 2023 , Zim Laboratories Ltd recorded a total revenue of approximately 365.47 Cr marking a significant milestone in the company's financial performance.
Zim Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..
Zim Laboratories Ltd's current PE ratio is 27.76.
Zim Laboratories Ltd's ROCE averaged 12.4% from the FY ending March 2022 to 2024, with a median of 12.3%. It peaked at 16.2% in March 2023, reflecting strong capital efficiency over the period..
Zim Laboratories Ltd's latest EBIT is Rs. 29.96 Cr, surpassing the average EBIT of Rs. 33.02 Cr over the 5 years..